半剂量FDG全身PET/CT与常规全剂量PET/CT在肺癌中的图像质量比较
结果显示G2图像质量评分4.3±0.7显著高于全剂量组3.7±0.6(p=0.004),肝脏SNR在G2为11.7±1.5显著高于全剂量组8.3±1.2(p<0.001),且以G15为参考G2和G4可识别全部病灶。
要点
- 半剂量全身PET/CT的G2和G4图像质量与常规全剂量PET/CT相当或更优。
- G2图像质量评分4.3±0.7显著高于全剂量组3.7±0.6(p=0.004)。
- 肝脏SNR随采集时间延长在G2、G4、G15间显著增加(均p<0.05)。
核心结论
- 半剂量18F-FDG全身PET/CT在G2和G4采集条件下图像质量与常规全剂量PET/CT相当,且优于临床常规全剂量PET/CT。
研究设计与样本
- 另匹配28例肺癌手术患者行全剂量(3.70 MBq/kg)常规PET/CT,半剂量组采集15分钟并分为G15、G4、G2,全剂量组扫描速度2分钟/床位。
主要发现
- G2图像质量评分4.3±0.7显著高于全剂量组3.7±0.6(p=0.004),G4和G15评分分别为4.9±0.2和5.0±0.0。
- G2肝脏SNR为11.7±1.5显著高于全剂量组8.3±1.2(p<0.001)。
- 肝脏SNR在G2、G4、G15间随采集时间显著增加,分别为11.1±1.7、15.2±3.4和30.5±6.0(均p<0.05)。
- 以G15为参考,G2和G4可识别全部病灶(100%)。
关键数值与推荐
- 半剂量组18F-FDG活度为1.85 MBq/kg,全剂量组为3.70 MBq/kg。
- 图像质量主观评分采用5分制(5分优,1分差)。
- 客观分析指标包括肝脏SUVmax、SUVmean和SNR,血池SUVmax和SUVmean,病灶SUVmax和靶本比(TBR)。
临床怎么用
- 在肺癌全身PET/CT中,采用半剂量18F-FDG并缩短采集时间至2分钟(G2)可获得优于常规全剂量PET/CT的图像质量。
- 半剂量全身PET/CT的G2和G4采集方案可保证病灶检出率与15分钟采集相当。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The purpose was to explore the effects of total-body PET/CT with half-dose 18F-FDG activity on image quality, compared with those of conventional PET/CT with clinical routine full-dose 18F-FDG in lung cancer. METHODS: Fifty-six primary lung cancer patients who underwent total-body PET/CT on a uEXPLORER scanner with half-dose (1.85 MBq/kg) 18F-FDG activity before treatment were retrospectively studied; among them, 28 patients were confirmed by postoperative pathologic examination and 28 patients by biopsy. After matching with the pathological study results, the other 28 patients with lung cancer who underwent surgery were selected for the full-dose (3.70 MBq/kg) group. Patients in the full-dose group were studied with a conventional uM780 PET/CT scanner. The acquisition time of the half-dose group was 15 min, split into 4-min and 2-min duration groups, which were all referred to as G15, G4 and G2, respectively. The PET/CT scanning speed in the full-dose group was 2 min/bed. Image quality was evaluated by subjective and objective analyses. The subjective analysis method was carried out with a 5-point scale (5-excellent, 1-poor). Objective analysis indicators of PET image quality included the SUVmax, SUVmean and signal-to-noise ratio (SNR) of the liver; the SUVmax and SUVmean of the blood pool; and the SUVmax and tumour-to-background ratio (TBR) of the lesions. G15 served as the reference for G2 and G4 to test lesion detectability. RESULTS: Image quality scores in G2 (4.3 ± 0.7) were significantly higher than those in the full-dose group (3.7 ± 0.6) (p = 0.004). The mean and SD of the image quality scores in G4 and G15 were 4.9 ± 0.2 and 5.0 ± 0.0, respectively. The liver SNR in G2 was significantly higher than that in the full-dose group; the corresponding SNR were 11.7 ± 1.5 and 8.3 ± 1.2 (p < 0.001), respectively. The liver SNR significantly increased with the time of acquisition among G2, G4 and G15 (11.1 ± 1.7, 15.2 ± 3.4 and 30.5 ± 6.0, all p < 0.05). G15 served as the reference, and all these lesions (100%) could be identified by G2 and G4. CONCLUSION: Total-body PET/CT with half-dose 18F-FDG activity in G2 and G4 achieved comparable image quality to conventional PET/CT, and its image quality was better than that of conventional PET/CT with clinical routine full-dose 18F-FDG in lung cancer.
引用
- Tan H, Sui X, Yin H, et al. Total-body PET/CT using half-dose FDG and compared with conventional PET/CT using full-dose FDG in lung cancer. Eur J Nucl Med Mol Imaging. 2020. PMID: 33244618. doi:10.1007/s00259-020-05091-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。